Roï Eisenkot joined CoMotion in 2014, where he manages a portfolio of diagnostic and therapeutic bioengineering technologies. Before, he spent six years at T3, the technology transfer arm of Technion – Israel Institute of Technology, where he led business development in the Physical Sciences, and initiated and structured deals as lead deal-maker for Technion with partners at various levels. Before that, he worked as Application Engineer for Dune Medical Devices. He managed Dune’s clinical site at Anne Arundel Medical Center in Annapolis, Maryland, and co-modeled Dune’s reimbursement plan for the US market. He holds an MBA with emphasis on strategy and entrepreneurship and a degree in biomedical engineering (summa cum laude) from Technion.